Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1989 1
1990 3
1992 1
1994 1
1995 1
1996 1
1997 1
2000 1
2003 3
2004 3
2005 3
2006 2
2007 3
2008 3
2009 2
2012 2
2013 4
2014 5
2015 1
2016 3
2017 1
2018 3
2019 2
2020 6
2021 6
2022 4
2023 3
2024 4
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Nutritional Aspects in Inflammatory Bowel Diseases.
Balestrieri P, Ribolsi M, Guarino MPL, Emerenziani S, Altomare A, Cicala M. Balestrieri P, et al. Nutrients. 2020 Jan 31;12(2):372. doi: 10.3390/nu12020372. Nutrients. 2020. PMID: 32023881 Free PMC article. Review.
Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease.
Bezzio C, Franchellucci G, Savarino EV, Mastronardi M, Caprioli FA, Bodini G, Variola A, Scaldaferri F, Furfaro F, Calabrese E, Principi MB, Biscaglia G, Marzo M, Michielan A, Cavalli C, Aratari A, Campigotto M, Ceccarelli L, Cappello M, Saibeni S, Balestrieri P, Soriano A, Casini V, Bertani L, Barberio B, Conforti FS, Danese S, Armuzzi A. Bezzio C, et al. Among authors: balestrieri p. Crohns Colitis 360. 2024 Oct 24;6(4):otae060. doi: 10.1093/crocol/otae060. eCollection 2024 Oct. Crohns Colitis 360. 2024. PMID: 39525291 Free PMC article. No abstract available.
Psychological distress in inflammatory bowel disease.
Balestrieri P, Cicala M, Ribolsi M. Balestrieri P, et al. Expert Rev Gastroenterol Hepatol. 2023 Jan-Jun;17(6):539-553. doi: 10.1080/17474124.2023.2209723. Epub 2023 May 30. Expert Rev Gastroenterol Hepatol. 2023. PMID: 37254523 Review.
Role of Overweight and Obesity in Gastrointestinal Disease.
Emerenziani S, Guarino MPL, Trillo Asensio LM, Altomare A, Ribolsi M, Balestrieri P, Cicala M. Emerenziani S, et al. Among authors: balestrieri p. Nutrients. 2019 Dec 31;12(1):111. doi: 10.3390/nu12010111. Nutrients. 2019. PMID: 31906216 Free PMC article. Review.
Pain and obesity in the older adult.
Taylor R Jr, Pergolizzi JV, Raffa RB, Nalamachu S, Balestrieri PJ. Taylor R Jr, et al. Among authors: balestrieri pj. Curr Pharm Des. 2014;20(38):6037-41. doi: 10.2174/1381612820666140316131431. Curr Pharm Des. 2014. PMID: 24641223 Review.
Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning-the IG-IBD LIVE study.
Pugliese D, Privitera G, Cersullo N, Bordekar H, Crispino F, Mezzina N, Pellegrini L, Allocca M, Laterza L, Viola A, Bertani L, Soru P, Scrivo B, Barberio B, Ricci C, Balestrieri P, Daperno M, Pluchino D, Rizzello F, Scribano ML, Sablich R, Pastorelli L, Manguso F, Variola A, Di Sario A, Grossi L, Ribaldone DG, Biscaglia G, Buda A, Mocci G, Viscido A, Di Paolo MC, Onali S, Rodino' S, Coletta M, Principi M, Miranda A, Amato A, Bezzio C, Petruzzellis C, Mazzuoli S, Festa S, Sartini A, Checchin D, Fanigliulo L, Gallina S, Cesarini M, Bodini G, Stradella D, Spagnuolo R, Guidi L, Savarino E, Cappello M, Caprioli F, Costa F, Fries W, Scaldaferri F, Fiorino G, Castiglione F, Massari A, Orlando A, Armuzzi A. Pugliese D, et al. Among authors: balestrieri p. Dig Liver Dis. 2025 May 12:S1590-8658(25)00736-4. doi: 10.1016/j.dld.2025.04.021. Online ahead of print. Dig Liver Dis. 2025. PMID: 40360308
Autonomy versus deontology.
Balestrieri PJ. Balestrieri PJ. Int J Obstet Anesth. 2009 Apr;18(2):189-90; author reply 190-1. doi: 10.1016/j.ijoa.2008.10.004. Epub 2009 Feb 4. Int J Obstet Anesth. 2009. PMID: 19195876 No abstract available.
Mathematical Modeling of Vedolizumab Treatment's Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients.
D'Ambrosio A, Altomare A, Boscarino T, Gori M, Balestrieri P, Putignani L, Del Chierico F, Carotti S, Cicala M, Guarino MPL, Piemonte V. D'Ambrosio A, et al. Among authors: balestrieri p. Bioengineering (Basel). 2024 Jul 12;11(7):710. doi: 10.3390/bioengineering11070710. Bioengineering (Basel). 2024. PMID: 39061792 Free PMC article.
69 results